Filter By Industry
Filter By Tag


sfbanc financial Press releases

1 - 1 of 1 Press Release

Aug 26, 2022
Simufilam is a leading candidate to become the first effective treatment for Alzheimer's Disease. In an analysis by sfbanc financial, Cassava Sciences, Inc. (SAVA) was upgraded as a Strong Buy, from 8/10 to 9.5/10.

sfbanc financial RSS Feed